Delivering Hope for Life
TLC BioSciences is a leading biotechnology research company committed to developing innovative nanomedicines. Utilizing its proprietary LipAD® lipid-assembled delivery system, TLC BioSciences focuses on enabling sustained release and targeted drug delivery to reduce toxicity and improve efficacy. The company's research and development efforts are primarily directed towards creating advanced therapies in pain management, oncology, ophthalmology, and infectious diseases.
TLC BioSciences operates globally, with key locations including its primary address at 2F, 3 Yuanqu Street, Nangang District, Taipei, 11503, TW. The company also has a presence at 611 Gateway Blvd, Suite 830, South San Francisco, California 94080, US; J.H. Oortweg 19, Leiden, 2333 CH Leiden, NL; and 4F Shinagawa East ONE Tower, 2-16-1 Konan, Minato-ku, Tokyo, 108-0075, JP. TLC BioSciences aims to maximize the potential of new medicines to enhance the quality of life for patients worldwide.
With a strong foundation in drug discovery and delivery, TLC BioSciences continues to push the boundaries of medical science. TLC BioSciences is dedicated to making a significant impact on global healthcare through groundbreaking research and development. We invite the manager of TLC BioSciences to create a customized and exclusive company showcase and product listing on our platform.
Compare TLC BioSciences with 3 companies in Biotechnology-Research
| Comparison Field |
TLC BioSciencesMain Company |
Sprint BioscienceView Profile |
Afecta Pharmaceutica...View Profile |
Columbus healthcare...View Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2009 | 2017 | |
|
Company Size
|
— | 11-50 | 2-10 | 51-200 |
|
City
|
Huddinge, Stockholm | Irvine, California | Los Angeles, CA | |
|
Country
|
Sweden | United States | United States | |
|
Skills & Keywords
Comparing with main company
|
10 Total Skills
Biotechnology
Nanomedicine
Drug Delivery
Oncology
Ophthalmology
Pain Management
Lipid-Assembled Delivery
Drug Discovery
Osteoarthritis
Drug Development
|
4 Total
4 Unique
Unique Skills:
Cancer
Fragment Based Drug Discovery
oncology therapeutics targeting cancer metabolism
Tumor Metabolism
|
16 Total
1 Common
15 Unique
Match
10%
Common Skills:
Biotechnology
Unique Skills:
505(b)(2)
Artificial Intelligence
Clinical Development
Dermatology
Gynecology
Medicinal Chemistry
+9
|
36 Total
36 Unique
Unique Skills:
Ambulatory Surgery
Anesthesiology
Behavior health
Cardiology
Chiropractics
Colorectal Surgery
+30
|
Other organizations in the same industry
This company is also known as